PBYI
8.25-1.52 -15.56%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- PBYI
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $425.87M
- Employees
- 179
- Currency
- USD
- Website
- https://www.pumabiotechnology.com
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops…
Latest coverage
- Puma: 3 Key Takeaways for Long-Term Investors
November 8, 2026